Morgan Stanley
ARTL icon

Morgan Stanley’s Artelo Biosciences ARTL Stock Holding History

Morgan Stanley’s Portfolio ARTL Stock Details ARTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-41
Closed -$5.05K – 8212
2025
Q3 		$5.05K Buy
+41
New +$11.3K ﹤0.01% 7084
2025
Q2 		– Hold
0
– – – 7760
2025
Q1 		– Hold
0
– – – 7980
2024
Q4 		– Hold
0
– – – 7858
2024
Q3 		– Hold
0
– – – 7799
2024
Q2 		– Hold
0
– – – 7696
2024
Q1 		– Hold
0
– – – 7627
2023
Q4 		– Hold
0
– – – 7630
2023
Q3 		– Hold
0
– – – 7520
2023
Q2 		– Hold
0
– – – 7548
2023
Q1 		– Hold
0
– – – 7612
2022
Q4 		– Hold
0
– – – 7714
2022
Q3 		– Hold
0
– – – 7696
2022
Q2 		– Hold
0
– – – 7795
2022
Q1 		– Hold
0
– – – 7950
2021
Q4 		– Hold
0
– – – 7968
2020
Q4 		– Hold
0
– – – 7030
2020
Q3 		– Hold
0
– – – 6724

Other funds holding ARTL

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
RIL
Rothschild Investment LLC Chicago, Illinois $2.68B AUM 34.39% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Morgan Stanley's ARTL Position: Q4 2025 in Review

Morgan Stanley sold out of Artelo Biosciences (ARTL) in Q4 2025, closing a stake of 41 shares — an estimated $5.05K sold.

Morgan Stanley first reported a position in ARTL in Q3 2025 and held it in 1 quarter. The position peaked at $5.05K in Q3 2025. 7 funds tracked by Wall St. Rank hold ARTL as of Q4 2025.

  • Morgan Stanley reported no remaining Artelo Biosciences position as of Q4 2025 after selling out during the quarter.
  • Morgan Stanley sold 41 Artelo Biosciences shares in Q4 2025, an estimated $5.05K.
  • Morgan Stanley first reported a position in Artelo Biosciences in Q3 2025 and held it in 1 quarter.
  • Morgan Stanley's Artelo Biosciences position peaked at $5.05K in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Artelo Biosciences as of Q4 2025.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.